Systematic review on the efficacy of multimodal treatment of sarcomatosis with cytoreduction and intraperitoneal chemotherapy

Annals of Surgical Oncology

Volumn 18, Issue 1, 2011, Pages 207-213

  Munene, Gitonga ^a   MacK, Lloyd A ^a   Temple, Walley J ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DOXORUBICIN; MITOMYCIN C; MITOXANTRONE;

ARTICLE; BLEEDING; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER GRADING; CANCER PATIENT; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL EFFECTIVENESS; CYTOREDUCTIVE SURGERY; DISEASE FREE SURVIVAL; EARLY POSTOPERATIVE CHEMOTHERAPY; HUMAN; HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; LENGTH OF STAY; MORBIDITY; MULTIMODALITY CANCER THERAPY; OBSERVATIONAL STUDY; OPERATION DURATION; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PERITONEUM CANCER; PERITONEUM SARCOMATOSIS; PROGNOSIS; PROSPECTIVE STUDY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SARCOMA; SURGICAL MORTALITY; SURVIVAL TIME; SYSTEMATIC REVIEW;

ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; CLINICAL TRIALS AS TOPIC; COMBINED MODALITY THERAPY; HUMANS; INJECTIONS, INTRAPERITONEAL; PERITONEAL NEOPLASMS; SARCOMA;

EID: 78651372008     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-010-1229-3     Document Type: Article

References (38)

1. SJ Lim JN Cormier BW Feig PF Mansfield RS Benjamin JR Griffin, et al. 2007 Toxicity and outcomes associated with surgical cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) for patients with sarcomatosis Ann Surg Oncol. 14 2309 2318 10.1245/s10434-007-9463-z 17541691
2. MM Bilimoria DJ Holtz NQ Mirza BW Feig PW Pisters S Patel, et al. 2002 Tumor volume as a prognostic factor for sarcomatosis Cancer. 94 2441 2446 10.1002/cncr.10504 12015769
3. DZ Chu NP Lang C Thompson PK Osteen KC Westbrook 1989 Peritoneal carcinomatosis in nongynecologic malignancy. A prospective study of prognostic factors Cancer. 63 364 367 1:STN:280:DyaL1M%2FovFGnsQ%3D%3D 10.1002/1097- 0142(19890115)63:2<364::AID-CNCR2820630228>3.0.CO;2-V 2910444
4. SS Mudan KC Conlon JM Woodruff JJ Lewis MF Brennan 2000 Salvage surgery for patients with recurrent gastrointestinal sarcoma: prognostic factors to guide patient selection Cancer. 88 66 74 1:STN:280:DC%2BD3c%2Fos1OnsA%3D%3D 10.1002/(SICI)1097-0142(20000101)88:1<66::AID-CNCR10>3.0.CO;2-0 10618607
5. CP Karakousis K Kontzoglou DL Driscoll 1997 Intraperitoneal chemotherapy in disseminated abdominal sarcoma Ann Surg Oncol. 4 496 498 1:STN:280: DyaK2svlsV2gsQ%3D%3D 10.1007/BF02303674 9309339
6. JS Spratt RA Adcock W Sherrill 1980 Hyperthermic peritoneal perfusion system in canines Cancer Res. 40 253 255 1:STN:280:DyaL3c%2FovFOrug%3D%3D 7356508
7. PH Sugarbaker 1995 Peritonectomy procedures Ann Surg. 221 29 42 1:STN:280:DyaK2M7is1OhsQ%3D%3D 10.1097/00000658-199501000-00004 7826158
8. G Confuorto ME Giuliano A Grimaldi C Viviano 2007 Peritoneal carcinomatosis from colorectal cancer: HIPEC? Surg Oncol 16 Suppl 1 S149 S152 10.1016/j.suronc.2007.10.026 18257149
9. J Esquivel R Sticca P Sugarbaker E Levine TD Yan R Alexander, et al. 2007 Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: a consensus statement. Society of Surgical Oncology Ann Surg Oncol. 14 128 133 1:STN:280:DC%2BD28jjtVyjsA%3D%3D 17072675
10. TD Yan D Black R Savady PH Sugarbaker 2007 A systematic review on the efficacy of cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei Ann Surg Oncol. 14 484 492 10.1245/s10434-006-9182-x 17054002
11. TD Yan D Black R Savady PH Sugarbaker 2006 Systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma J Clin Oncol. 24 4011 4019 10.1200/JCO.2006.07.1142 16921055
12. TD Yan M Deraco D Baratti S Kusamura D Elias O Glehen, et al. 2009 Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma: Multi-Institutional Experience J Clin Oncol. 27 6237 6242 10.1200/JCO.2009.23.9640 19917862
13. DK Armstrong B Bundy L Wenzel HQ Huang R Baergen S Lele, et al. 2006 Intraperitoneal cisplatin and paclitaxel in ovarian cancer N Engl J Med. 354 34 43 1:CAS:528:DC%2BD28XhvV2qsQ%3D%3D 10.1056/NEJMoa052985 16394300
14. VJ Verwaal S Bruin H Boot G van Slooten H van Tinteren 2008 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer Ann Surg Oncol. 15 2426 2432 10.1245/s10434-008-9966-2 18521686
15. CR Rossi P Casali S Kusamura D Baratti M Deraco 2008 The consensus statement on the locoregional treatment of abdominal sarcomatosis J Surg Oncol. 98 291 294 10.1002/jso.21067 18726899
16. PH Sugarbaker 2001 Review of a personal experience in the management of carcinomatosis and sarcomatosis Jpn J Clin Oncol. 31 573 583 1:STN:280:DC%2BD387ntVSmsw%3D%3D 10.1093/jjco/hye088 11902487
17. O Glehen FN Gilly 2003 Quantitative prognostic indicators of peritoneal surface malignancy: carcinomatosis, sarcomatosis, and peritoneal mesothelioma Surg Oncol Clin N Am. 12 649 671 10.1016/S1055-3207(03)00037-1 14567023
18. P Jacquet PH Sugarbaker 1996 Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis Cancer Treat Res. 82 359 374 1:STN:280:DyaK2s%2Fgt1Kitw%3D%3D 8849962
19. NJ Gusani SW Cho C Colovos S Seo J Franko SD Richard, et al. 2008 Aggressive surgical management of peritoneal carcinomatosis with low mortality in a high-volume tertiary cancer center Ann Surg Oncol. 15 754 763 10.1245/s10434-007-9701-4 18080166
20. EA Levine JH Stewart 2007 4th, Russell GB, Geisinger KR, Loggie BL, Shen P. Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy for peritoneal surface malignancy: experience with 501 procedures J Am Coll Surg 204 943 953 10.1016/j.jamcollsurg.2006.12.048 17481516 discussion 953-5
21. S Kusamura F Raspagliesi D Baratti A Gronchi P Casali M Deraco 2004 Uterine sarcoma treated by cytoreductive surgery and intraperitoneal hyperthermic perfusion: a feasibility study J Chemother 16 Suppl 5 19 22 15675470
22. CR Rossi M Deraco M De Simone S Mocellin P Pilati M Foletto, et al. 2004 Hyperthermic intraperitoneal intraoperative chemotherapy after cytoreductive surgery for the treatment of abdominal sarcomatosis: clinical outcome and prognostic factors in 60 consecutive patients Cancer. 100 1943 1950 10.1002/cncr.20192 15112276
23. S Bonvalot A Cavalcanti C Le Pechoux P Terrier D Vanel JY Blay, et al. 2005 Randomized trial of cytoreduction followed by intraperitoneal chemotherapy versus cytoreduction alone in patients with peritoneal sarcomatosis Eur J Surg Oncol. 31 917 923 1:STN:280:DC%2BD2MrhtlaltQ%3D%3D 10.1016/j.ejso.2005.04.010 15975759
24. FC Eilber G Rosen C Forscher SD Nelson FJ Dorey FR Eilber 1999 Surgical resection and intraperitoneal chemotherapy for recurrent abdominal sarcomas Ann Surg Oncol. 6 645 650 1:STN:280:DC%2BD3c%2FitlGjtw%3D%3D 10.1007/s10434-999- 0645-8 10560849
25. B Berthet TA Sugarbaker D Chang PH Sugarbaker 1999 Quantitative methodologies for selection of patients with recurrent abdominopelvic sarcoma for treatment Eur J Cancer. 35 413 419 1:STN:280:DyaK1MznslCjsw%3D%3D 10.1016/S0959-8049(98)00375-X 10448292
26. B Berthet PH Sugarbaker 1998 The role of intraperitoneal chemotherapy after curative excision of primary abdominopelvic sarcoma Ann Chir. 52 607 611 1:STN:280:DyaK1M%2Fit1Kguw%3D%3D 9805797
27. TD Yan L Welch D Black PH Sugarbaker 2007 A systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for diffuse malignancy peritoneal mesothelioma Ann Oncol. 18 827 834 1:STN:280:DC%2BD2s3ns1eqsg%3D%3D 10.1093/annonc/mdl428 17130182
28. P Bao D Bartlett 2009 Surgical techniques in visceral resection and peritonectomy procedures Cancer J. 15 204 211 10.1097/PPO.0b013e3181a9c6f0 19556906
29. JL Speyer JM Collins RL Dedrick MF Brennan AR Buckpitt H Londer, et al. 1980 Phase I and pharmacological studies of 5-fluorouracil administered intraperitoneally Cancer Res. 40 567 572 1:STN:280:DyaL3M7jsFGltA%3D%3D 7471076
30. WP Ceelen MF Flessner 2010 Intraperitoneal therapy for peritoneal tumors: biophysics and clinical evidence Nat Rev Clin Oncol. 7 108 115 10.1038/nrclinonc.2009.217 20010898
31. CP Karakousis LE Blumenson G Canavese U Rao 1992 Surgery for disseminated abdominal sarcoma Am J Surg. 163 560 564 1:STN:280:DyaK383otV2rtQ%3D%3D 10.1016/0002-9610(92)90556-7 1375814
32. RG da Silva PH Sugarbaker 2006 Analysis of prognostic factors in seventy patients having a complete cytoreduction plus perioperative intraperitoneal chemotherapy for carcinomatosis from colorectal cancer J Am Coll Surg. 203 878 886 10.1016/j.jamcollsurg.2006.08.024 17116556
33. BN Moradi III J Esquivel 2009 Learning curve in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy J Surg Oncol. 100 293 296 10.1002/jso.21326 19697425
34. Gastrointestinal Stromal Tumor Meta-Analysis Group (MetaGIST). Comparison of two doses of imatinib for the treatment of unresectable or metastatic gastrointestinal stromal tumors: a meta-analysis of 1,640 patients. J Clin Oncol. 2010;28:1247-53.
35. Pisters PW, Patel SR. Gastrointestinal stromal tumors: Current management. J Surg Oncol. 2010 [Epub ahead of print].
36. F Mohamed BJ Moran 2009 Morbidity and mortality with cytoreductive surgery and intraperitoneal chemotherapy: the importance of a learning curve Cancer J. 15 196 199 10.1097/PPO.0b013e3181a58d56 19556904
37. RP McQuellon BW Loggie RA Fleming GB Russell AB Lehman TD Rambo 2001 Quality of life after intraperitoneal hyperthermic chemotherapy (IPHC) for peritoneal carcinomatosis Eur J Surg Oncol. 27 65 73 1:STN:280: DC%2BD3M7osFWksg%3D%3D 10.1053/ejso.2000.1033 11237495
38. GM Mavligit AA Zukiwski PA Salem L Lamki S Wallace 1991 Regression of hepatic metastases from gastrointestinal leiomyosarcoma after hepatic arterial chemoembolization Cancer. 68 321 323 1:STN:280:DyaK3MzgtVChtA%3D%3D 10.1002/1097-0142(19910715)68:2<321::AID-CNCR2820680219>3.0.CO;2-B 2070331